Brandon J. DeKosky joined the Department of Chemical Engineering as an assistant professor in a newly introduced joint faculty position between the department and the Ragon Institute of MGH, MIT and Harvard in September 2021. He received his BS in chemical engineering from University of Kansas, and his PhD in chemical engineering from the University of Texas at Austin. He then did postdoctoral research at the Vaccine Research Center of the National Institute of Infectious Diseases. In 2017, Brandon launched his independent academic career as an assistant professor at the University of Kansas in a joint position with the Department of Chemical Engineering and the Department of Pharmaceutical Chemistry. He was also a member of the bioengineering graduate program. His research program focuses on developing and applying a suite of new high-throughput experimental and computational platforms for molecular analysis of adaptive immune responses, and to accelerate precision drug discovery. He has received several notable recognitions, which include receipt of the NIH K99 Path to Independence and NIH DP5 Early Independence Award, the Cellular and Molecular Bioengineering Rising Star Award from the Biomedical Engineering Society, and the Career Development Award from the Congressionally Directed Medical Research Program’s Peer Reviewed Cancer Research Program.